About Penta
Who we are
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Publications
Contact us
Work with us
Vacancies
Call for services
Archivio
Pharmacokinetics (PK) of Nelfinavir (NFV) and its Active Metabolite (M8) in Very Young Infants Infected with Human Immunodeficiency Virus (HIV)
Evolution of drug resistance in antiretroviral therapy-naïve children in PENTA 5
T cell repopulation in HIV infected children on highly active anti-retroviral therapy (HAART)
Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T+ddI+Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants : 24 Week Preliminary Results from the PENTA 7 Study